Cannabinoids and the Coronavirus

Article Properties
  • Language
    English
  • Publication Date
    2020/06/01
  • Indian UGC (journal)
  • Refrences
    19
  • Citations
    22
  • Kevin P. Hill Division of Addiction Psychiatry, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.
Journal Categories
Medicine
Public aspects of medicine
Toxicology
Poisons
Medicine
Therapeutics
Pharmacology
Refrences
Title Journal Journal Categories Citations Publication Date
Cannabidiol for Viral Diseases: Hype or Hope? Cannabis and Cannabinoid Research
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Therapeutics. Pharmacology
19 2020
Cannabinoids and Viral Infections Pharmaceuticals
  • Medicine: Pharmacy and materia medica
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
44 2010
10.1128/CVI.00636-12
10.1212/WNL.0000000000000250
Assessment of Efficacy and Tolerability of Medicinal Cannabinoids in Patients With Multiple Sclerosis JAMA Network Open
  • Medicine
  • Medicine: Medicine (General)
  • Medicine: Internal medicine
  • Medicine: Medicine (General)
43 2018
Citations
Title Journal Journal Categories Citations Publication Date
Impact of nutraceuticals on immunomodulation against viral infections—A review during COVID‐19 pandemic in Indian scenario

Journal of Biochemical and Molecular Toxicology
  • Science: Biology (General)
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Public aspects of medicine: Toxicology. Poisons
1 2023
An overview of phytochemical constituents and pharmacological implications of Cannabis sativa L. Journal of Herbal Medicine
  • Medicine: Other systems of medicine
  • Medicine: Medicine (General)
2023
Antiviral Activity of Cannabidiolic Acid and Its Methyl Ester against SARS-CoV-2 Journal of Natural Products
  • Science: Botany: Plant ecology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Agriculture
  • Agriculture: Agriculture (General)
  • Medicine: Public aspects of medicine: Toxicology. Poisons
1 2023
Tocilizumab-coated solid lipid nanoparticles loaded with cannabidiol as a novel drug delivery strategy for treating COVID-19: A review

Frontiers in Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
3 2023
Endocannabinoid System: Chemical Characteristics and Biological Activity

Pharmaceuticals
  • Medicine: Pharmacy and materia medica
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
11 2023
Citations Analysis
The category Science: Biology (General) 8 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Cannabis and COVID-19: Reasons for Concern and was published in 2020. The most recent citation comes from a 2023 study titled An overview of phytochemical constituents and pharmacological implications of Cannabis sativa L.. This article reached its peak citation in 2021, with 9 citations. It has been cited in 19 different journals, 42% of which are open access. Among related journals, the Molecules cited this research the most, with 3 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year